Company Filing History:
Years Active: 1998-2000
Title: Zeljko Kelneric: Innovator in Pharmaceutical Chemistry
Introduction
Zeljko Kelneric is a prominent inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new antibiotics. With a total of four patents to his name, Kelneric's work has the potential to impact the treatment of bacterial infections.
Latest Patents
Kelneric's latest patents include innovative compounds such as ketolides from the class of 15-membered lactams. One of his notable inventions relates to new 15-membered ketoazalides, specifically 6-O-methyl-8a-aza-8a-homo- and 6-O-methyl-9a-aza-9a-homoerythromycin A. These compounds are characterized by a general formula that includes specific functional groups, which enhance their efficacy as antibiotics. Additionally, he has developed β,β-disubstituted derivatives of 9-deoxo-9a-N-ethenyl-9a-aza-9a-homoerythromycin A, which are new semisynthetic antibiotics belonging to the macrolide class. These inventions are crucial for the preparation of pharmaceutical compositions aimed at treating bacterial infections.
Career Highlights
Zeljko Kelneric is associated with Pliva, a leading pharmaceutical, chemical, food, and cosmetic industry company. His work at Pliva has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been recognized within the industry, showcasing his expertise and commitment to advancing medical science.
Collaborations
Kelneric has collaborated with notable colleagues such as Gorjana Lazarevski and Gabrijela Kobrehel. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the field.
Conclusion
Zeljko Kelneric's work exemplifies the spirit of innovation in pharmaceutical chemistry. His patents and collaborations reflect a dedication to improving healthcare through the development of new antibiotics. His contributions are vital in the ongoing fight against bacterial infections, showcasing the importance of research and innovation in medicine.